Race Oncology EMD AML Trial Featured on NBN News

17 Nov
Nov , 17 , 2022 Daniel Tillett
LinkedIn

Related posts:

Race Oncology Investor Briefing – Melbourne 20th Oct 2022 Race CMO Dr David Fuller Talks to Proactive about latest Zantrene Trial News Zantrene AML Trial at Chaim Sheba, Israel Advances to Phase 2